Natural Killer Cell Symposium in Krems
(Krems, 04.05.2023) The NK Cell Symposium in Krems was a pivotal gathering spotlighting the role of natural killer (NK) cells in cancer immunotherapy. Researchers from the St. Anna CCRI and other institutions shared their latest findings, emphasizing NK cells’ potential as a powerful tool in combating cancer.
The NK Cell Symposium brought together research groups focusing on understanding different aspects of Natural Killer cell biology. Esteemed researchers from the St. Anna CCRI, VetMedUni and the and other renowned institutions converged to unveil their pioneering findings, illustrating the formidable capabilities of NK cells as a key player in the fight against cancer.
New findings on NK cells
Eva König, who was part of St. Anna CCRI until end of 2023 and now moved to MUW, showcased groundbreaking research on NK cells’ ability to target and eliminate malignant cells together with her team. Michelle Buri’s talk revealed unknown mechanisms by which leukemic cells evade NK cell detection. Faith David focused on identifying novel molecular targets to enhance NK cell-based therapies for leukemia. Hayeon Baik explored the role of serine/threonine kinase 38 (STK38) in NK cells, potentially crucial for their anti-cancer activity.
A Collaborative Effort Toward Cancer Solutions
The highlight of the symposium was the lecture by Dietmar Herndler Brandstetter, an expert in tumor immunology from the MUW. His keynote on NK cell-targeted therapy exemplified the symposium’s focus on translational research. This collaborative platform not only shared cutting-edge science but also fostered partnerships, advancing our collective knowledge in the fight against cancer.